1. Home
  2. VTRS vs WBS Comparison

VTRS vs WBS Comparison

Compare VTRS & WBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
    SELLHOLDBUYas of 15 hours ago
  • WBS
    SELLHOLDBUYas of 15 hours ago
  • Stock Information
  • Founded
  • VTRS 1961
  • WBS 1935
  • Country
  • VTRS United States
  • WBS United States
  • Employees
  • VTRS N/A
  • WBS N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • WBS Major Banks
  • Sector
  • VTRS Health Care
  • WBS Finance
  • Exchange
  • VTRS Nasdaq
  • WBS Nasdaq
  • Market Cap
  • VTRS 11.0B
  • WBS 9.1B
  • IPO Year
  • VTRS N/A
  • WBS N/A
  • Fundamental
  • Price
  • VTRS $8.98
  • WBS $48.52
  • Analyst Decision
  • VTRS Hold
  • WBS Buy
  • Analyst Count
  • VTRS 4
  • WBS 14
  • Target Price
  • VTRS $10.50
  • WBS $62.14
  • AVG Volume (30 Days)
  • VTRS 15.7M
  • WBS 1.2M
  • Earning Date
  • VTRS 02-27-2025
  • WBS 04-22-2025
  • Dividend Yield
  • VTRS 5.35%
  • WBS 3.27%
  • EPS Growth
  • VTRS N/A
  • WBS N/A
  • EPS
  • VTRS N/A
  • WBS 4.37
  • Revenue
  • VTRS $14,739,300,000.00
  • WBS $2,366,786,000.00
  • Revenue This Year
  • VTRS N/A
  • WBS $8.76
  • Revenue Next Year
  • VTRS $0.99
  • WBS $6.29
  • P/E Ratio
  • VTRS N/A
  • WBS $11.19
  • Revenue Growth
  • VTRS N/A
  • WBS N/A
  • 52 Week Low
  • VTRS $8.77
  • WBS $39.34
  • 52 Week High
  • VTRS $13.55
  • WBS $63.99
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 25.27
  • WBS 28.44
  • Support Level
  • VTRS $9.25
  • WBS $47.27
  • Resistance Level
  • VTRS $9.74
  • WBS $56.96
  • Average True Range (ATR)
  • VTRS 0.38
  • WBS 1.87
  • MACD
  • VTRS -0.07
  • WBS -0.68
  • Stochastic Oscillator
  • VTRS 7.61
  • WBS 12.90

Stock Price Comparison Chart: VTRS vs WBS

VTRS
WBS
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober202505101520253035404550556065VTRS VS WBS

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About WBS Webster Financial Corporation

Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use